The Government intends to introduce an electronic cigarette regulatory scheme. The Ministry of Health has established a Technical Expert Advisory Group on Electronic Cigarette Product Safety.
This group will provide advice on the technical aspects of the development of the regulatory scheme, such as appropriate minimum quality and safety standards in the New Zealand context. These standards include manufacturing, ingredients, labelling and packaging.
Members of the group are:
Rebecca Ruwhiu-Collins is the founder of Vape2Save, a programme which comprises of harm reduction support to quit smoking tobacco and financial capability. The Vape2Save programme was launched in 2015 and has particularly helped Māori and Pacific people to quit smoking tobacco. Rebecca has over 10 years’ experience in Health and brings a consumer perspective to the group through her expertise in treatment, national training for tobacco addiction and community mobilisation and development.
Dr Paul Marshall
Dr Paul Marshall is the chair of the British Standards Institution (BSi) committee on electronic cigarettes and e-liquids and is a member of working group 4 of the European Committee for Standardization (CEN) committee on e-cigarette and e-liquid standards. Prior to his current role as a consultant to the pharmaceutical industry, Paul was a senior pharmaceutical assessor for 11 years at the UK Medicines and Healthcare products Regulatory Agency (MHRA), a Technical Advisory Board member and expert assessor for the European Directorate for the Quality of Medicines & Healthcare certification scheme (EDQM) and the chair of the joint European CHMP/CVMP/CMDh/CMDv working group on Active Substance Master File (ASMF) procedures. Paul brings an understanding of the international market for alternative tobacco and nicotine-delivery products.
Dr Penelope Truman
Dr Penelope Truman is a biochemist with an interest in unravelling complex toxicological problems. She worked for many years on improving the monitoring system for marine biotoxins, developing biochemical and cell-based test systems that would detect and evaluate toxicity from currently unknown toxins. She currently teaches in the Environmental Health area at Massey University, Wellington. Her research focus is on nicotine and tobacco dependence, where understanding the effect on dependence of switching to vaping from smoking is an important research need. Penelope brings knowledge of the risks and benefits associated with the use of e-cigarettes.
Nell Rice manages e-cigarette purchasing for the Cosmic retail stores. Her role also involves researching vaping-related science and collating product information to educate shop-floor staff. Nell brings both an understanding of the e-cigarette and e-liquid market in New Zealand and understanding of the retail sale of e-cigarettes and e-liquid.
Dr Murray Winiata
Murray Winiata is a South Auckland-based General Practitioner, Fellow of the Royal New Zealand College of General Practitioners, and Advanced Trainee of the New Zealand College of Urgent Care. Murray is a former smoker who quit with (and still uses) e-cigarettes. Murray brings both knowledge of the risks and benefits associated with the use of e-cigarettes and a consumer perspective.
Prof. Julian Crane
Julian Crane is a research professor and Director of the Wellington Asthma Research Group based in the Department of Medicine at the University of Otago, Wellington. Julian’s current research interests are in respiratory and allergic health including impact of poor housing on health and a longstanding research interest in alternative nicotine delivery in smoking cessation. Julian brings both an understanding of the e-cigarette and e-liquid market in New Zealand, and knowledge of the risks and benefits associated with the use of e-cigarettes.
QJ Satchell is a former smoker, using e-cigarettes since 2012. Since this time QJ has been operating his business NZVAPOR, advocating for the vaping community and driving for legislative introduction of minimum production standards of e-liquids. QJ brings both an understanding of the manufacture, importation, and/or retail sale of e-cigarettes and e-liquid, and the e-cigarette and e-liquid market in New Zealand.
Andrew has over 30 years international business experience and has been involved in the electronic cigarette industry since 2012. Andrew's experience in creating global internet businesses has focussed on disruptive technologies and innovations all aimed at facilitating positive change within their respective market places. Andrew brings an understanding of the international market for alternative tobacco and nicotine-delivery products.
Dr Hayden McRobbie (group chair)
Hayden McRobbie is Professor in Public Health Interventions at Barts and The London School of Medicine and Dentistry, Queen Mary University of London (QMUL) and Director of the Dragon Institute for Innovation. Hayden is highly experienced in undertaking large randomised controlled trials of both pharmacological and behavioural interventions for smoking cessation and in studies that examine nicotine delivery from nicotine replacement therapy and alternative nicotine delivery products. Hayden provides advice to a range of international organisations and expert bodies, committees, working groups and conferences. He is Assistant Editor of Nicotine and Tobacco Research and Addiction, Deputy Editor of the Journal of Smoking Cessation, and a member of the Society for Research of Nicotine and Tobacco (SRNT).